McDermott Will & Emery has advised TreeFrog Therapeutics on the deal. TreeFrog Therapeutics, a French biotech company aiming to unlock access to cell therapies for millions...
TreeFrog Therapeutics’ Licensing Agreement with Vertex
Cousin Surgery’s Acquisition of PlantTec Medical
McDermott Will & Emery advised Cousin Surgery. Cousin Surgery, a French group specialized in implantable medical devices with a longstanding industrial expertise, has announced its acquisition of PlantTec...
Pierre Fabre’s Signature of a Collaboration and Licensing Agreement with Scorpion Therapeutics
McDermott advised Pierre Fabre in this transaction. The French pharmaceutical and dermo-cosmetic company, Pierre Fabre, has recently entered into an exclusive collaboration and licensing agreement with...
TreeFrog Therapeutics’ Collaboration with GAIA BioMedicine
McDermott Will & Emery advised TreeFrog Therapeutics on its collaboration with GAIA BioMedicine. GAIA BioMedicine and TreeFrog Therapeutics have entered into a collaboration to expand donor-derived...
Advicenne’s Agreement with Taïba Healthcare
McDermott Will & Emery advised Advicenne on the deal. Advicenne, a pharmaceutical company specializing in the development and commercialization of innovative treatments for those suffering from...
TreeFrog Therapeutics’ Collaboration with Umoja Biopharma
McDermott Will & Emery has advised TreeFrog Therapeutics on the deal. TreeFrog Therapeutics, a French-based biotech company aiming to unlock access to cell therapies for millions...
Aelis Farma’s IPO on Euronext Paris
IN BRIEF: McDermott Will & Emery, advised on the matter. McDermott Will & Emery advised AELIS FARMA with a team including Joseph Marx (Equity Capital Markets),...
Atara Biotherapeutics’ Strategic Agreement with Pierre Fabre
McDermott Will & Emery advised Pierre Fabre on the deal. Pierre Fabre finalized a strategic collaboration with Atara Biotherapeutics to commercialize Tab-cel® in Europe, the Middle East,...
AELIS FARMA’s Collaboration and Option-license Agreement With INDIVIOR
IN BRIEF: McDermott Will & Emery, advised on the matter. McDermott Will & Emery advised AELIS FARMA with a team including Emmanuelle Trombe (Picture – Life...
Puma Biotechnology and Pierre Fabre’s Amendment of NERLYNX License Agreement
IN BRIEF: McDermott Will & Emery, advised on the matter. McDermott Will & Emery advised Pierre Fabre S.A. with a team including Anne-France Moreau (Life Science...